Works matching IS 15228517 AND DT 2011 AND VI 13 AND IP 12


Results: 18
    1

    Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma.

    Published in:
    Neuro-Oncology, 2011, v. 13, n. 12, p. 1331, doi. 10.1093/neuonc/nor130
    By:
    • Butowski, Nicholas;
    • Chang, Susan M.;
    • Lamborn, Kathleen R.;
    • Polley, Mei–Yin;
    • Pieper, Russell;
    • Costello, Joseph F.;
    • Vandenberg, Scott;
    • Parvataneni, Rupa;
    • Nicole, Angelina;
    • Sneed, Patricia K.;
    • Clarke, Jennifer;
    • Hsieh, Emily;
    • Costa, Bruno M.;
    • Reis, Rui M.;
    • Hristova-Kazmierski, Maria;
    • Nicol, Steven J.;
    • Thornton, Donald E.;
    • Prados, Michael D.
    Publication type:
    Article
    2
    3

    Cover Page.

    Published in:
    Neuro-Oncology, 2011, v. 13, n. 12, p. NP, doi. 10.1093/neuonc/nor211
    Publication type:
    Article
    4
    5

    Editorial Board.

    Published in:
    Neuro-Oncology, 2011, v. 13, n. 12, p. NP, doi. 10.1093/neuonc/nor212
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Society news.

    Published in:
    Neuro-Oncology, 2011, v. 13, n. 12, p. 1379, doi. 10.1093/neuonc/nor213
    Publication type:
    Article
    16
    17

    Subscription Page.

    Published in:
    Neuro-Oncology, 2011, v. 13, n. 12, p. NP, doi. 10.1093/neuonc/nor214
    Publication type:
    Article
    18

    Contents Page.

    Published in:
    Neuro-Oncology, 2011, v. 13, n. 12, p. NP, doi. 10.1093/neuonc/nor210
    Publication type:
    Article